MedPath

Choir Singing in Aphasia Rehabilitation

Not Applicable
Completed
Conditions
Aphasia
Stroke
Registration Number
NCT03501797
Lead Sponsor
University of Helsinki
Brief Summary

This study evaluates the verbal, cognitive, emotional, and neural efficacy of a choir singing intervention in chronic aphasic patients and their caregivers. Using a cross-over RCT design, half of the participants receive a 4-month singing intervention during the first half of the study and half of the participants during the second half of the study.

Detailed Description

BACKGROUND: Singing is a highly stimulating and versatile activity for the brain, combining vocal-motor, auditory, linguistic, cognitive, emotional, and social brain processes, both in the left and right hemisphere. The capacity to sing is often preserved in aphasia after stroke, and singing-based methods, such as Melodic Intonation Therapy (MIT), can be effective in rehabilitating speech production in aphasics. Also emotionally and socially, singing could provide a powerful alternative channel for aphasic patients to express their emotions and interact with others, but the communal or group-level use of singing in aphasia rehabilitation has not been systematically studied.

AIMS: The purpose of the study is to determine the clinical and neural efficacy of a novel choir singing intervention in subacute/chronic aphasia. Specifically, the targeted outcomes are (i) verbal and vocal-motor skills, (ii) cognitive skills, (iii) emotional functioning and quality of life, (iv) caregiver psychological well-being, and (v) structural and functional neuroplasticity. In addition, the capacity of singing and music learning in aphasia is explored.

METHODS: Subjects are 60 stroke patients with at least minor aphasia (≥ 6 months post-stroke) and their family members (FMs, N = 60) from Helsinki area recruited to a cross-over RCT study. Participants are randomized to two groups \[N = 60 in both (30 patients, 30 FMs)\], which receive a 16-week choir intervention either during the first (AB group) or second (BA group) half of the follow-up. The intervention is a combination of group training, which utilizes a novel combination of traditional senior choir singing and MIT-like speech training protocols, and home training in which the choir material is trained with a tablet computer. All patients are evaluated at baseline, 5-month, and 9-month stages with language, cognitive, and auditory-music tests and questionnaires. Half of the patients (N = 30) also undergo electroencephalography (EEG) and structural and functional magnetic resonance imaging (s/fMRI). FMs are evaluated with questionnaires.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Verbal agilityChange from baseline at 5 months and 9 months

Verbal Agility subtest score of the Boston Diagnostic Aphasia Examinaton (BDAE) (range 0-14, higher score indicates better outcome)

Verbal comprehensionChange from baseline at 5 months and 9 months

Sequential Commands subtest score of the Western Aphasia Battery (WAB) (range 0-80, higher score indicates better outcome)

Connected speech informativenessChange from baseline at 5 months and 9 months

Percentage of correct information units (CIUs) produced in a picture description task

Communication abilityChange from baseline at 5 months and 9 months

Total score of the Communication Action Log (CAL) questionnaire (range 0-180, higher score indicates better outcome)

Repetition of words and sentencesChange from baseline at 5 months and 9 months

Repetition subscale score of the Western Aphasia Battery (WAB) (range 0-100, higher score indicates better outcome)

Spontaneous speech productionChange from baseline at 5 months and 9 months

Spontaneous Speech subscale score of the Western Aphasia Battery (WAB) (range 0-20, higher score indicates better outcome)

Naming and word findingChange from baseline at 5 months and 9 months

Naming and Word Finding subscale score of the Western Aphasia Battery (WAB) (range 0-100, higher score indicates better outcome)

Secondary Outcome Measures
NameTimeMethod
Executive function (correct responses)Change from baseline at 5 months and 9 months

Simon Task: score (range 0-100, higher score indicates better outcome)

Attention (reaction times)Change from baseline at 5 months and 9 months

Flexible Attention Test (FAT): reaction time mean (ms)

Verbal learningChange from baseline at 5 months and 9 months

Word Lists subtest score of the Wechsler Memory Scale III (WMS-III) (range 0-84, higher score indicates better outcome)

Psychological stress of the caregiverChange from baseline at 5 months and 9 months

Total score of the General Health Questionnaire (GHQ-12) (range 0-36, lower score indicates better outcome)

Electroencephalography (EEG)Change from baseline at 5 months and 9 months

Amplitude and latency of event-related potentials (ERPs) associated with learning and memory in two auditory tasks

Structural magnetic resonance imaging (sMRI): DTI sequenceChange from baseline at 5 months and 9 months

Structural connectivity of intra- and interhemispheric white matter tracts

Functional magnetic resonance imaging (fMRI): resting-stateChange from baseline at 5 months and 9 months

resting-state fMRI sequence: functional connectivity of frontotemporal, frontoparietal, and limbic brain networks

Verbal memoryChange from baseline at 5 months and 9 months

Logical Memory subtest score of the Wechsler Memory Scale III (WMS-III) (range 0-80, higher score indicates better outcome)

Music perceptionChange from baseline at 5 months and 9 months

Montreal Battery of Evaluation of Amusia (MBEA) score (range 0-30, higher score indicates better outcome)

DepressionChange from baseline at 5 months and 9 months

Total score of the Center for Epidemiological Studies Depression Scale (CES-D) questionnaire (range 0-60, lower score indicates better outcome)

Caregiver burdenChange from baseline at 5 months and 9 months

Total score of the Zarit Burden Interview (ZBI-22) questionnaire (range 0-88, lower score indicates better outcome)

Structural magnetic resonance imaging (sMRI): MPRAGE sequenceChange from baseline at 5 months and 9 months

Grey matter volume in frontotemporal, frontoparietal, and limbic brain regions

Functional magnetic resonance imaging (fMRI): singing-related activityChange from baseline at 5 months and 9 months

task-based fMRI sequence: frontotemporal, frontoparietal, and limbic activation patterns associated with the perception, vocal repetition, and recall of novel songs

Executive function (reaction times)Change from baseline at 5 months and 9 months

Simon Task: reaction time mean (ms)

Attention (correct responses)Change from baseline at 5 months and 9 months

Flexible Attention Test (FAT): score (range 0-48, higher score indicates better outcome)

Functional stroke recoveryChange from baseline at 5 months and 9 months

Total score of the Stroke Impact Scale (SIS) questionnaire (range 0-900, higher score indicates better outcome)

Social interactionChange from baseline at 5 months and 9 months

Total score of the Social Provision Scale (SPS) questionnaire (range 24-96, higher score indicates better outcome)

Working memoryChange from baseline at 5 months and 9 months

Word Span subtest score of the Kielelliset Arviointitehtävät (KAT) (range 0-30, higher score indicates better outcome)

Singing abilityChange from baseline at 5 months and 9 months

Acoustic features (e.g., pitch, rhythm, intensity) analyzed from recorded production of familiar and novel songs using acoustic analysis software

MoodChange from baseline at 5 months and 9 months

Total score of the Visual Analog Mood Scales (VAMS) questionnaire (range 0-800, higher score indicates better outcome)

Trial Locations

Locations (2)

Helsinki University Central Hospital, Department of Neurology, Rehabilitation Unit

🇫🇮

Helsinki, Finland

Helsinki-Uusimaa Aphasia and Stroke Association

🇫🇮

Helsinki, Finland

Helsinki University Central Hospital, Department of Neurology, Rehabilitation Unit
🇫🇮Helsinki, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.